Editorial. Discusses the health risks associated with synthetic hormone diethylstilbestrol (DES) which was prescribed to pregnant women in the U.S. from 1940 to 1971 to prevent miscarriage. Role of DES in hormone-related cancers; Educational campaign launched by the U.S. Center for Disease Control about DES; Prevalence of clear cell adenocarcinoma in DES daughters.